Cingulate CINGW
NASDAQ CINGW
$0.01 +0.00 (+4.29%)
As of: Sep 9, 2026 · 11:16 AM EDT

Cingulate (CINGW) Total Current Liabilities (2021 - 2026)

Cingulate's (CINGW) quarterly Total Current Liabilities came in at $8.6 million in Q2 2026, down 16.31% quarter-over-quarter from $10.3 million in Q4 2025.

Analysis

Cingulate (CINGW) Total Current Liabilities (2021 - 2026) Analysis & Trends

Cingulate (CINGW) has reported Total Current Liabilities for 6 consecutive years, with $8.6 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Total Current Liabilities changed N/A year-over-year to $8.6 million; the trailing twelve-month figure through Jun 2026 stood at $8.6 million (changed N/A YoY), and the FY2025 full-year result was $10.3 million, up 107.41% from the prior year.
  • Total Current Liabilities declined to $8.6 million in Q2 2026 per CINGW's latest filing, from $10.3 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $11.0 million in Q2 2023 and bottomed at $923505.0 in Q2 2022.
  • Historically, Total Current Liabilities has averaged $5.7 million across 5 years, with a median of $5.8 million in 2023.
  • The sharpest annual moves came in 2023 and 2024: Total Current Liabilities jumped 1090.56% in 2023, then slumped 81.42% in 2024.
  • Over 5 years, Total Current Liabilities stood at $7.0 million in 2022, then jumped by 45.82% to $10.2 million in 2023, then tumbled by 51.38% to $5.0 million in 2024, then jumped by 107.41% to $10.3 million in 2025, then dropped by 16.31% to $8.6 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $8.6 million, $10.3 million, and $5.9 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 644.46 Bn 623.70 Bn 17.26 Bn 54.90 Bn
2 AbbVie 440.11 Bn 433.54 Bn 12.70 Bn 41.64 Bn
3 Merck 365.04 Bn 357.90 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 266.82 Bn 259.13 Bn 11.24 Bn 31.75 Bn
5 Pfizer 159.14 Bn 147.45 Bn 10.94 Bn 32.65 Bn
6 Sanofi 52.47 Bn 45.09 Bn 10.79 Bn 37.11 Bn
7 Revolution Medicines 44.26 Bn 44.26 Bn - 354.06 Mn
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn 1.31 Bn
9 United Therapeutics 21.46 Bn 18.80 Bn 683.80 Mn 607.80 Mn
10 Cingulate 100,214.03 100,214.03 - 8.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.63 Mn
Dec 31, 2025 10.31 Mn
Sep 30, 2025 5.88 Mn
Mar 31, 2025 5.62 Mn
Dec 31, 2024 4.97 Mn
Sep 30, 2024 1.54 Mn
Jun 30, 2024 2.04 Mn
Mar 31, 2024 2.25 Mn
Dec 31, 2023 10.23 Mn
Sep 30, 2023 5.73 Mn
Jun 30, 2023 10.99 Mn
Mar 31, 2023 6.66 Mn
Dec 31, 2022 7.01 Mn
Sep 30, 2022 6.41 Mn
Jun 30, 2022 923,505.00
Mar 31, 2022 1.63 Mn
Dec 31, 2021 1.18 Mn